RESEARCH-USE BIOSIMILAR ANTIBODY
Picankibart
Monoclonal antibody · IgG1
Picankibart is a human-derived IgG1κ antibody targeting IL23A. Picankibart specifically binds to the IL23 p19 subunit and exerts an anti-inflammatory effect by blocking the IL23-mediated signaling pathway.
TARGETIL23A
YMonoclonal antibody
CATALOGSC-BS-266
CATALOG NUMBERSC-BS-266
MOLECULAR WEIGHTApprox. 144.744 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Picankibart is a human-derived IgG1κ antibody targeting IL23A. Picankibart specifically binds to the IL23 p19 subunit and exerts an anti-inflammatory effect by blocking the IL23-mediated signaling pathway.
Picankibart is a recombinant research-use antibody directed against IL23A.